According to FT, citing sources close to the matter, the offer would price Hologic’s shares between $70 and $72, substantially above Friday’s closing price of $54.28. Investors appeared to react to ...

Following the earnings release, the stock rose 1.1% to $83.39 at yesterday’s close. Let’s briefly go through Hologic’s performance ... led by a 10.5% surge in Molecular Diagnostics.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

The biggest reason for this surge was Hologic's impressive earnings report ... basically suggests that everyone's undervaluing this stock. That's tough to agree with, especially with the way ...

Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, ...

Hologic stock (NASDAQ NDAQ: HOLX), a medical devices company focused on women’s health, has seen a 19% fall this year, faring slightly better than the broader S&P500 index, down 24%. Even if we ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

This was the stock's second consecutive day of losses.